Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
CytoSorb sales8.59M91.44%
Grant income777.59K8.28%
Other Sales26.52K0.28%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
All other countries18.05M49.67%
Germany12.96M35.67%
United States5.33M14.67%